Hitzenbichler, F. and Olic, J. and Hanses, F. and Salzberger, B. and Fischer, M. and Baessler, A. (2019) Current treatment of endocarditis Innovations and controversies. INTERNIST, 60 (10). pp. 1111-1117. ISSN 0020-9554, 1432-1289
Full text not available from this repository. (Request a copy)Abstract
Despite many novel diagnostic strategies and advances in treatment, infective endocarditis (IE) remains a severe disease. The epidemiology of IE has shifted and staphylococci have replaced streptococci as the most common cause and nosocomially acquired infections, invasive procedures, indwelling cardiac devices and acquired infections due to intravenous drug abuse are more frequent. The incidence of IE has steadily increased in recent years and the patients affected are older and have more comorbidities. The modern treatment of IE is interdisciplinary. The pharmacotherapy of IE depends on the pathogen and its sensitivity. The presence of a bioprosthetic valve and implantable cardiac devices plays a significant role in selection of antibiotics and duration of treatment. This article provides an update and overview of the current clinical practice in diagnostics and pharmacotherapy of IE in adults with a special focus on partial oral therapy and the role of aminoglycosides.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | INFECTIVE ENDOCARDITIS; DUKE CRITERIA; DIAGNOSIS; MANAGEMENT; ECHOCARDIOGRAPHY; TOMOGRAPHY; GUIDELINES; Endocarditis; epidemiology; Antibacterial agents; Aminoglycosides; Foreign bodies; Staphylococcus |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 26 Mar 2020 13:55 |
| Last Modified: | 26 Mar 2020 13:55 |
| URI: | https://pred.uni-regensburg.de/id/eprint/26163 |
Actions (login required)
 |
View Item |
